Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5842440 | Life Sciences | 2012 | 7 Pages |
Abstract
Altogether these findings provide additional support to the potential use of ETAR and EGFR blockade as a new therapeutic opportunity for EOC treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Roberta Cianfrocca, Piera Tocci, Francesca Spinella, Valeriana Di Castro, Anna Bagnato, Laura Rosanò,